CPHI AMEX
China Pharma Holdings, Inc.
1W: -14.7%
1M: -24.1%
3M: -6.1%
YTD: -47.0%
1Y: -67.0%
3Y: -90.8%
5Y: -99.8%
$0.66
+0.00 (+0.61%)
Weekly Expected Move ±8.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$466K
+33.3% ▲
Capital Expenditures
$292K
-2432.9% ▼
5Y CAGR: +16.5%
Free Cash Flow
-$758K
-6.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$797K
-31.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$3M | -$4M | -$3M | -$5M |
| Depreciation & Amort. | $3M | $3M | $3M | $3M | $3M |
| Stock-Based Comp. | $0 | $15K | $78K | $0 | $0 |
| Change in Working Capital | $30K | $52K | $878K | -$396K | $1M |
| Other Non-Cash Items | $115K | -$5K | -$94K | $22K | $456K |
| Operating Cash Flow | -$42K | -$250K | -$410K | -$700K | -$466K |
| — Investing Activities — | |||||
| Capital Expenditures | -$867K | -$438K | -$402K | -$12K | -$38K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$253K |
| Investing Cash Flow | -$867K | -$438K | -$402K | -$12K | -$292K |
| — Financing Activities — | |||||
| Net Debt Issuance | $624K | $5M | -$2M | $73K | $27K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$223K | $0 | $0 |
| Financing Cash Flow | $624K | $5M | -$2M | $73K | $27K |
| Net Change in Cash | -$227K | $4M | -$3M | -$606K | -$797K |
| Cash End of Period | $958K | $5M | $2M | $1M | $627K |
| Free Cash Flow | -$910K | -$688K | -$812K | -$711K | -$758K |